Bristol-Myers Squibb Co <BMY.N>: Leerink Partners raises target price to $73.00 from $67.00
BMY•Related News
AbbVie beats Q2 revenue, adjusted EPS estimates but cuts FY adj EPS guidance
ABBV•
Forex-Yen steady as traders remain alert to intervention risks
TLT•
Moog Q3 sales beat on growth across segments, lifts FY outlook
MOG.A•
Castellum updates financial calendar with Q2 earnings release and conference call
CTM•
AbbVie falls after trimming 2026 profit forecast
ABBV•